2/6/2013

The FDA is considering developing a quality scorecard for drug manufacturers in an effort to prevent quality problems that have contributed to recent drug shortages, according to an article in Clinical Pharmacology & Therapeutics by FDA officials Janet Woodcock and Marta Wosinka.

Full Story:
Pharmalot

Related Summaries